Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial

NCT01149369 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

NIH

Sponsor class

Conditions

Gastroparesis

Interventions

DRUG: Aprepitant
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)